Moreover, ANXA2 has also been reported to be a target of miR-155, a critical miRNA in neuroinflammation at the BBB and relevant in Th1 and Th17 cell differentiation and myeloid cell polarization in MS as mentioned above [165]. This evidence concerns the gene ANXA2 and myeloid sarcoma.